Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


25.09.2017

3 Acta Psychiatr Scand
1 Am J Med Genet B Neuropsychiatr Genet
2 J Clin Psychiatry
1 J Clin Psychopharmacol
1 Med J Aust
1 Mol Psychiatry
3 PLoS One
3 Psychiatry Res
3 Psychol Med
8 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. VERDOUX H, Pambrun E, Tournier M, Bezin J, et al
    Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.
    Acta Psychiatr Scand. 2017;135:429-438.
    PubMed     Text format     Abstract available

  2. JAKOBSEN MI, Larsen JR, Svensson CK, Johansen SS, et al
    The significance of sampling time in therapeutic drug monitoring of clozapine.
    Acta Psychiatr Scand. 2017;135:159-169.
    PubMed     Text format     Abstract available

  3. KOHLER O, Petersen L, Mors O, Mortensen PB, et al
    Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study.
    Acta Psychiatr Scand. 2017;135:97-105.
    PubMed     Text format     Abstract available


    Am J Med Genet B Neuropsychiatr Genet

  4. DE KLUIVER H, Buizer-Voskamp JE, Dolan CV, Boomsma DI, et al
    Paternal age and psychiatric disorders: A review.
    Am J Med Genet B Neuropsychiatr Genet. 2017;174:202-213.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  5. HAIG GM, Wang D, Zhao J, Othman AA, et al
    Efficacy and Safety of the alpha7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11162. doi: 10.4088/JCP.16m11162.
    PubMed     Text format     Abstract available

  6. PUIG O, Baeza I, de la Serna E, Cabrera B, et al
    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11122. doi: 10.4088/JCP.16m11122.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  7. SAJATOVIC M, Ramirez LF, Fuentes-Casiano E, Cage J, et al
    A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk of Treatment Nonadherence and Homelessness.
    J Clin Psychopharmacol. 2017 Sep 19. doi: 10.1097/JCP.0000000000000778.
    PubMed     Text format     Abstract available


    Med J Aust

  8. CASTLE DJ, Galletly CA, Dark F, Humberstone V, et al
    The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders.
    Med J Aust. 2017;206:501-505.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  9. ZHOU Y, Dong F, Lanz TA, Reinhart V, et al
    Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment.
    Mol Psychiatry. 2017 Sep 19. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    PLoS One

  10. DE CASTRO-CATALA M, Mora-Solano A, Kwapil TR, Cristobal-Narvaez P, et al
    The genome-wide associated candidate gene ZNF804A and psychosis-proneness: Evidence of sex-modulated association.
    PLoS One. 2017;12:e0185072.
    PubMed     Text format     Abstract available

  11. SULLIVAN S, Northstone K, Gadd C, Walker J, et al
    Models to predict relapse in psychosis: A systematic review.
    PLoS One. 2017;12:e0183998.
    PubMed     Text format     Abstract available

  12. DECUYPERE F, Sermon J, Geerts P, Denee TR, et al
    Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
    PLoS One. 2017;12:e0179049.
    PubMed     Text format     Abstract available


    Psychiatry Res

  13. KILICASLAN EE, Esen AT, Kasal MI, Ozelci E, et al
    Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30902.
    PubMed     Text format     Abstract available

  14. WATSON AJ, Joyce EM, Fugard AJB, Leeson VC, et al
    More haste less speed: A meta-analysis of thinking latencies during planning in people with psychosis.
    Psychiatry Res. 2017 Sep 5. pii: S0165-1781(17)30175.
    PubMed     Text format     Abstract available

  15. VANCAMPFORT D, Gorczynski P, De Hert M, Probst M, et al
    Exercise self-efficacy correlates in people with psychosis.
    Psychiatry Res. 2017 Sep 8. pii: S0165-1781(17)30413.
    PubMed     Text format     Abstract available


    Psychol Med

  16. DONOHOE G, Dillon R, Hargreaves A, Mothersill O, et al
    Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Psychol Med. 2017 Sep 21:1-14. doi: 10.1017/S0033291717001982.
    PubMed     Text format     Abstract available

  17. GAUGHRAN F, Lally J, Beck K, McCormack R, et al
    Brain-relevant antibodies in first-episode psychosis: a matched case-control study.
    Psychol Med. 2017 Sep 18:1-9. doi: 10.1017/S0033291717002689.
    PubMed     Text format     Abstract available

  18. TIN LNW, Lui SSY, Ho KKY, Hung KSY, et al
    High-functioning autism patients share similar but more severe impairments in verbal theory of mind than schizophrenia patients.
    Psychol Med. 2017 Sep 18:1-12. doi: 10.1017/S0033291717002690.
    PubMed     Text format     Abstract available


    Schizophr Res

  19. GILL KM, Miller SA, Grace AA
    Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Schizophr Res. 2017 Sep 15. pii: S0920-9964(17)30540.
    PubMed     Text format     Abstract available

  20. SCHJERNING O, Damkier P, Lykkegaard SE, Jakobsen KD, et al
    Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.
    Schizophr Res. 2017 Sep 14. pii: S0920-9964(17)30575.
    PubMed     Text format     Abstract available

  21. JOSHI YB, Breitenstein B, Tarasenko M, Thomas ML, et al
    Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia.
    Schizophr Res. 2017 Sep 15. pii: S0920-9964(17)30279.
    PubMed     Text format     Abstract available

  22. BOUSMAN CA, Lee TY, Kim M, Lee J, et al
    Genetic variation in cytokine genes and risk for transition to psychosis among individuals at ultra-high risk.
    Schizophr Res. 2017 Sep 12. pii: S0920-9964(17)30516.
    PubMed     Text format    

  23. DUGRE JR, Guay JP, Dumais A
    Risk factors of compliance with self-harm command hallucinations in individuals with affective and non-affective psychosis.
    Schizophr Res. 2017 Sep 11. pii: S0920-9964(17)30545.
    PubMed     Text format     Abstract available

  24. LIU Y, Rao S, Xu Y, Zhang F, et al
    Changes in the level of Long Non-Coding RNA Gomafu gene expression in schizophrenia patients before and after antipsychotic medication.
    Schizophr Res. 2017 Sep 11. pii: S0920-9964(17)30502.
    PubMed     Text format    

  25. MUNOZ-ESTRADA J, Lora-Castellanos A, Meza I, Alarcon Elizalde S, et al
    Primary cilia formation is diminished in schizophrenia and bipolar disorder: A possible marker for these psychiatric diseases.
    Schizophr Res. 2017 Sep 16. pii: S0920-9964(17)30530.
    PubMed     Text format     Abstract available

  26. HURFORD IM, Ventura J, Marder SR, Reise SP, et al
    A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Schizophr Res. 2017 Sep 13. pii: S0920-9964(17)30510.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: